Abidin Gülmüş – CEO, GEN
Few Turkish companies are experiencing such a transformational moment as GEN. Just in 2021, the Ankara-based organization made its public debut at the…
Tagged with IPO
China Biopharma Dealmaking Review H1 2021
The latest reporting on China biopharma dealmaking from MSQ Ventures, including the Top 10 biotech in-licensing deals in H1 2021, the Top 5…
HKEX’s Aim to Become World’s #1 Biotech Listing Hub &…
With three years having passed since the Hong Kong Stock Exchange (HKEX)’s decision to allow pre-revenue biotechs to IPO, we look back at a stellar…
China: EpimAb Looks to 2022 IPO & Global Leadership in…
Hot on the heels of a USD 120 million fundraising round, Shanghai-based EpimAb Biotherapeutics is now looking towards a 2022 IPO with the aim of…
Carl Firth – CEO, ASLAN Pharmaceuticals
ASLAN Pharmaceuticals is a clinical-stage immunology-focused biopharmaceutical company. CEO Dr Carl Firth reveals why the company has shifted its…
5 Top Trends in Chinese Healthcare & Biopharma in 2020
2020 has been eventful – perhaps the understatement of the year – but despite the novel coronavirus being discovered in China around the beginning…
China Biopharma Dealmaking 2020 Review
While many parts of the world ground to a halt as they tried to deal with the global pandemic, China had more or less brought the situation under…
2020’s Top 7 Biotech IPOs in Profile
Following the recent news of Remegen's massive USD 515 million IPO in November 2020, we bring you profiles of the seven biggest biotech companies to…
China: 2020’s Biggest Biotech IPO in Profile
RemeGen, a low-profile Chinese biotech company based in Yantai city in the coastal Shandong province, around nine hours by train from the bustling…
HKEX SVP Reflects on Two Years of Pre-Revenue Biotech IPO…
It has been just over two years since the Hong Kong Stock Exchange (HKEX) revised its listing rules to allow pre-revenue biotechs to IPO as long as…
Hong Kong Biotech IPOs since Listing Reform in April 2018
On 30 April 2018, Hong Kong Stock Exchange’s (HKEX’s) introduced a number of reforms to allow and support the listing of pre-profit biotech…
China Pharma News Roundup July 24th 2020
A roundup of latest news from Chinese pharma and biotech, including a record high share price for Hansoh, strategic healthcare partnerships, venture…
